The Medical Journal of Australia
Prediabetes: The Looming Burden for Australia
CommentaryIndustry & policy
Papers by Gideon Meyerowitz-Katz
2 results
- Diabetes, Obesity & Metabolism
Cardiorenal Mortality and Safety Outcomes of GLP-1 Receptor Agonists in Type 2 Diabetes With BMI Below 27 kg/m²: A Target Trial Emulation
Cohort study of 8,969 peopleGLP-1 receptor agonists